Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment 5. Debunking Myths in the US Healthcare System
Top Ten Searches
aldosteronism contrast dialysis vitamin d bicarbonate arf amyloidosis hypocalcemia renal artery husYour Article Summary
See Latest ArticlesImpact of Charlson’s comorbidity index on overall survival following tumor nephrectomy for renal cell carcinoma
International Urology and Nephrology, 08/31/09
Ather MH et al. – There was significant improvement in the quality of life, following tumor nephrectomy, even for Stage–IV cancers. Multivariate analysis indicated besides tumor stage, grade, and size of the tumor, Charlson’s index has a significant predictive value on overall survival.
M. Hammad Ather, 09/01/09
| Surgery continues to be the main stay of treatment for most renal cancers. Recent introduction of targeted therapy is opening new horizon in the management of advanced and metastatic renal cancer, though overall survival is not significantly different. The overall survival besides the oncological factors is greatly dependant on the co morbid factors. Charlson's index is an objective way of assessing the biological factors affecting overall prognosis besides cancer. In the current work we noted that the overall survival in patients treated by radical or tumor nephrectomy for renal cancer is not only dependant on the tumor specific variables like grade, tumor type, and pathological stage but is also significantly influenced by patient specific variables like co morbidity, gender and age. Charlson's index provides a validated instrument to provide improved preoperative prognostic evaluation. |
Related Articles
Chromosomal abnormalities of clear cell renal cell carcinoma: Frequent gain of chromosome 7
Pathology International, 11/19/09
Relevance Score: 89%
Glycogen synthase kinase-3: a new therapeutic target in renal cell carcinoma
British Journal of Cancer, 11/20/09
Relevance Score: 84%
Population-based survey of cancer risks in chromosome 3 translocation carriers
Genes, Chromosomes and Cancer, 10/28/09
Relevance Score: 84%
Apolipoprotein E/C1 Locus Variants Modify Renal Cell Carcinoma Risk
Cancer Research, 10/20/09
Relevance Score: 84%
Surgical Treatment of Renal Cell Carcinoma in the Immunocompromised Transplant Patient
Urology, 10/12/09
Relevance Score: 84%
Today in Hematology/Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Efficacy and safety of pazopanib in patients with metastatic renal cell carcinoma
Journal of Clinical Oncology, 12/18/09
Renal cell carcinoma with caval involvement: Contemporary strategies of surgical treatment
Urologic Oncology: Seminars and Original Investigations, 12/18/09
Antiproliferative and apoptosis inducing effects of indirubin-3'-monoxime in renal cell cancer cells
Urologic Oncology: Seminars and Original Investigations, 12/18/09
Article Search
Sponsor